Costa Mesa, CA (PRWEB) December 26, 2013
WCCT Global, a full service CRO headquartered in Southern California is pleased to announce a new company wide milestone for the quickest completion of a Clinical Study. WCCT Global was able to take a study from final protocol to last subject completion in just two weeks. This accomplishment is testament to the efficiency of the entire WCCT Global study implementation process. The company has made a commitment to be as efficient as possible for all sponsors. The timeline consisted of WCCT Global being awarded the study on December 3rd and received final protocol on December 5th. Screening consisted of 54 subjects were screened from December 12th through December 17th. The study volunteers checked in on December 18th and completed the study on December 19th. The clinical research coordinating staff at WCCT Global is structured in a way where they can implement all aspects of the study to perform in the most efficient way possible.
WCCT Global’s recruitment department played an intricate role in the study’s success by selecting possible volunteers for the study from their fully engaged “opt-in” database. The volunteers were able to quickly be screened and randomized. This process is testament to the patient recruitment process that WCCT Global has been recognized for industry wide. WCCT Global’s Recruitment Manager Sean Lopez stated, “I am proud to announce this great feat with completing this study in the 2 week timeline. It is our goal for every clinical study to offer sponsors the quickest recruitment programs available.” WCCT Global continues to pioneer what is possible from a full service contract research organization.
More About WCCT Global
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including first-in-human (FIH), as well as specific therapeutic expertise in allergy, asthma, HCV, ophthalmology, oncology, renal, and vaccines.
If you would like to learn more about WCCT Global, click here.
Read the full story at http://www.prweb.com/releases/2013/12/prweb11447383.htm.
Copyright©2012 Vocus, Inc.
All rights reserved